The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - PharmaEssentia
Leadership - PharmaEssentia
Stock and Other Ownership Interests - PharmaEssentia
Proposal of an endpoint for a phase III clinical study of essential thrombocythemia: Balancing between short term effects and long term benefits.
 
Ruben A. Mesa
Honoraria - AOP Orphan Pharmaceuticals; Novartis; shire
Consulting or Advisory Role - Baxalta; Galena Biopharma; Incyte; Novartis
Research Funding - Celgene (Inst); CTI (Inst); Genentech (Inst); Gilead Sciences (Inst); Incyte (Inst); NS Pharma (Inst); Pfizer (Inst); Pharmaessentia (Inst); Promedior (Inst)
Travel, Accommodations, Expenses - AOP Orphan Pharmaceuticals; Incyte; Novartis
 
Craig Zimmerman
Employment - PharmaEssentia
Leadership - PharmaEssentia
Stock and Other Ownership Interests - PharmaEssentia
 
Lih Lisa Kang
Employment - PharmaEssentia
Leadership - PharmaEssentia
Stock and Other Ownership Interests - PharmaEssentia
 
Albert Qin
No Relationships to Disclose
 
Chungwei Lee
Employment - PharmaEssentia
Leadership - PharmaEssentia
Stock and Other Ownership Interests - PharmaEssentia
 
Weichung (Joe) Shih
Consulting or Advisory Role - Merck; PharmaEssentia
 
Oleh Zagrijtschuk
Leadership - PharmaEssentia
Honoraria - PharmaEssentia
 
Norio Komatsu
Consulting or Advisory Role - Japan Tobacco Inc; PharmaEssentia
Speakers' Bureau - Novartis; PharmaEssentia; Shire
Research Funding - FUSO Pharmaceutical; PharmaEssentia; Shire; Wako Pure Chemical Industries Ltd.
 
Zhi-Jian Xiao
No Relationships to Disclose
 
Hsin-An Hou
Honoraria - Bristol-Myers Squibb; Celgene; Chugai Pharma; Johnson & Johnson; Kirin Pharmaceuticals; Merck Sharp & Dome; Novartis; Pfizer; PharmaEssentia; Roche; Takeda
 
Chih-Cheng Chen
Speakers' Bureau - PharmaEssentia
 
Srdan Verstovsek
Consulting or Advisory Role - Celgene; Constellation Pharmaceuticals; Incyte; Novartis; Pragmatist; Sierra Oncology
Research Funding - Blueprint Medicines; Celgene; CTI BioPharma Corp; Genentech; Gilead Sciences; Incyte; Novartis; NS Pharma; Promedior; Roche